NASDAQ · STOCK

Thermo Fisher Scientific

TMO Life Sciences Tools & Services Unknown Updated July 08, 2026
$509.95
52W $403.36 – $643.99
54/100
$191.14B
28.0
0.86
AI Committee Verdict
Hold
+5.4%
-3.2%
1.68:1
75%
Bull & Bear Case
Bull Case
  • Positive MACD histogram signals bullish momentum.
  • Weekly trend: uptrend.
  • Daily downtrend but weekly uptrend — possible early reversal but not yet confirmed on the daily.
  • Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
Insufficient data for bear case.
AI Investment Committee
Committee Consensus As of July 08, 2026
Overall Committee Score
54/100
The AI Investment Committee is an ensemble of six specialized analytical agents: Value Analyst, Technical Analyst, Growth Analyst, Risk Analyst, Macro Analyst, and News Analyst. Each agent independently evaluates TMO using dedicated data signals, then the committee aggregates their verdicts into a final score and recommendation. This multi-agent approach reduces individual model bias and provides a more balanced investment assessment.
View Full Committee Breakdown in Terminal →
Technical Analysis
RSI (14)
59.1
Neutral
MACD Histogram
2.849
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$494.22
Resistance
$538.40
Bollinger %B
0.73
Inside Bands
Price vs Moving Averages
EMA 9
$508.19 Above
EMA 21
$495.74 Above
EMA 50
$487.99 Above
EMA 200
$505.16 Above
Fundamental Analysis
Valuation
54
Growth
45
Profitability
65
Financial Health
89
Valuation
P/E Ratio 28.0×
P/B Ratio 4.08×
PEG Ratio
Dividend Yield 0.36%
52W High $643.99
52W Low $403.36
Quality & Growth
ROE 1324.0%
ROA 640.0%
Gross Margin 4089.0%
Operating Margin 1746.0%
Revenue Growth YoY +536.0%
Debt / Equity 0.74
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 28.0 (moderate relative to a 15-40x range); Price-to-book of 4.1x; Revenue growth (YoY) of 5.4%; EPS growth (YoY) of 6.7%; Return on equity of 13.2%; Return on assets of 6.4%; Net margin of 15.2%; Gross margin of 40.9%; Current ratio of 1.89 (healthy short-term liquidity); Debt-to-equity of 0.74; Earnings-history trend unavailable; growth based on TTM year-over-year only.
Key Risks
Risk data not available for TMO.
Get the Full TMO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile